Model
Edge
BioCryst Pharmaceuticals Inc
0001221599
Filing Type
4
Filing Date
6/8/2022
Updated
6/9/22, 10:36 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership